Alpa Laboratorie

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE385I01010
  • NSEID: ALPA
  • BSEID: 532878
INR
49.97
-0.64 (-1.26%)
BSENSE

Nov 20

BSE+NSE Vol: 16.66 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 476646,
    "name": "Alpa Laboratorie",
    "stock_name": "Alpa Laboratorie",
    "full_name": "Alpa Laboratories Ltd",
    "name_url": "stocks-analysis/alpa-laboratorie",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "49.97",
    "chg": -0.64,
    "chgp": "-1.26%",
    "dir": -1,
    "prev_price": "50.61",
    "mcapval": "106.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532878,
    "symbol": "ALPA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE385I01010",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "16.66 k",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/alpa-laboratorie-476646-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Alpa Laboratories Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/alpa-laboratories-ltd-is-rated-strong-sell-4267969",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AlpaLaboratorie_mojoScore_4267969.png",
        "date": "2026-11-19 10:10:24",
        "description": "Alpa Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 November 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Alpa Laboratories Ltd Downgraded to Strong Sell Amid Deteriorating Quality Metrics",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/alpa-laboratories-ltd-downgraded-to-strong-sell-amid-deteriorating-quality-metrics-4265757",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AlpaLaboratorie_qualitydot_4265757.png",
        "date": "2026-11-18 08:00:19",
        "description": "Alpa Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a significant downgrade in its quality grading from average to below average, prompting MarketsMojo to revise its Mojo Grade from Sell to Strong Sell as of 17 Nov 2025. This shift reflects a marked deterioration in key business fundamentals including profitability, growth consistency, and capital efficiency, raising concerns for investors amid a challenging market backdrop."
      },
      {
        "title": "Alpa Laboratories Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/alpa-laboratories-ltd-is-rated-strong-sell-4245441",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/AlpaLaboratorie_mojoScore_4245441.png",
        "date": "2026-10-31 10:10:13",
        "description": "Alpa Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 14 August 2026, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 31 October 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Alpa Laboratories Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/alpa-laboratories-ltd-is-rated-strong-sell-4207155",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AlpaLaboratorie_mojoScore_4207155.png",
        "date": "2026-09-28 10:10:23",
        "description": "Alpa Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 August 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 28 September 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Alpa Laboratories Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/alpa-laboratories-ltd-is-rated-strong-sell-4195026",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AlpaLaboratorie_mojoScore_4195026.png",
        "date": "2026-09-16 10:10:19",
        "description": "Alpa Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 August 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 16 September 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Alpa Laboratories Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/alpa-laboratories-ltd-is-rated-strong-sell-4177772",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AlpaLaboratorie_mojoScore_4177772.png",
        "date": "2026-09-01 10:10:26",
        "description": "Alpa Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      }
    ],
    "total": 33,
    "sid": "476646",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/alpa-laboratories-476646"
  },
  "announcements": [
    {
      "caption": "Board Meeting Outcome for Results For The Quarter And Half Year Ended September 302026.",
      "datetime": "14-Nov-2026",
      "details": "Results for the quarter and half year ended September 302026.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results Of The Company For The Quarter And Half Year Ended On 30Th September 2026 Along With Limited Review Report Thereon.",
      "datetime": "04-Nov-2026",
      "details": "Alpa Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 inter alia to consider and approve 1. To consider and approve the un-Audited Standalone & Consolidated financial results of the Company for the quarter and half-year ending September 30 2026.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "14-Oct-2026",
      "details": "Alpa Laboratories Limited hereby submit to the Exchange the Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Prticipants) Regulations 2018.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Board Meeting Outcome for Results For The Quarter And Half Year Ended September 302026.

14-Nov-2026 | Source : BSE

Results for the quarter and half year ended September 302026.

Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results Of The Company For The Quarter And Half Year Ended On 30Th September 2026 Along With Limited Review Report Thereon.

04-Nov-2026 | Source : BSE

Alpa Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 inter alia to consider and approve 1. To consider and approve the un-Audited Standalone & Consolidated financial results of the Company for the quarter and half-year ending September 30 2026.

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

14-Oct-2026 | Source : BSE

Alpa Laboratories Limited hereby submit to the Exchange the Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Prticipants) Regulations 2018.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available